StockData

NuCana plc (NCNA) stock

NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 1/30
$0.86−0.07 (-7.53%)

Close on Nov 16, 2026Market cap $3.58MP/E –Yield –

NuCana operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

NuCana's operating cash flow for the twelve months ending Dec 31, 2021 was -£23.82M. For fiscal 2025 it was -£7.47M. The highest annual figure on record is -£4.47M in fiscal 2015.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-£7.47M–
FY2024Dec 31, 2024-£19.12M–
FY2023Dec 31, 2023-£26.44M–
FY2022Dec 31, 2022-£23.16M–
FY2021Dec 31, 2021-£23.82M–
FY2020Dec 31, 2020-£21.62M–
FY2019Dec 31, 2019-£23.83M–
FY2018Dec 31, 2018-£12.22M–
FY2017Dec 31, 2017-£8.71M–
FY2016Dec 31, 2016-£9.26M–
FY2015Dec 31, 2015-£4.47M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2021Dec 31, 2021-£10.09M–
Q3 FY2021Sep 30, 2021-£805.00K–
Q2 FY2021Jun 30, 2021-£4.86M–
Q1 FY2021Mar 31, 2021-£8.07M–
Q4 FY2020Dec 31, 2020-£8.98M–
Q3 FY2020Sep 30, 2020-£4.99M–
Q2 FY2020Jun 30, 2020-£1.44M–
Q1 FY2020Mar 31, 2020-£6.21M–
Q4 FY2019Dec 31, 2019-£3.86M–
Q3 FY2019Sep 30, 2019-£8.34M–
Q2 FY2019Jun 30, 2019-£5.54M–
Q1 FY2019Mar 31, 2019-£6.09M–
Q4 FY2018Dec 31, 2018-£2.34M–
Q3 FY2018Sep 30, 2018-£3.99M–
Q2 FY2018Jun 30, 2018-£3.14M–
Q1 FY2018Mar 31, 2018-£2.76M–
Q4 FY2017Dec 31, 2017-£3.18M–
Q3 FY2017Sep 30, 2017-£1.94M–

More NuCana figures

See a number that looks wrong?